The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

Share Price Information for CATCo (CAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 13.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 22.00 (169.231%)
Open: 24.00
High: 24.00
Low: 24.00
Prev. Close: 24.00
CAT Live PriceLast checked at -
CATCo Reinsurance Opportunities is an Investment Trust

To provide investors with significant capital returns and long-term distributions by making investments linked to catastrophe reinsurance risks via a variety of insurance-based investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

10 Sep 2015 07:00

RNS Number : 6162Y
CATCo Reinsurance Opps Fund Ltd
10 September 2015
 

 

 

CATCo Reinsurance Opportunities Fund Ltd. ("the Company")

 

CATCo Investment Management Ltd. Sale of Assets

 

 

To: SFM, London Stock Exchange and Bermuda Stock Exchange

Date: 10 September 2015

 

The Company announces that its investment manager, CATCo Investment Management Ltd. ("CATCo IM") has agreed to sell substantially all its assets to Markel Corporation ("Markel"), a U.S. based diverse financial holding company whose principal business markets and underwrites specialty insurance products. Listed on the New York Stock Exchange, Markel has a market capitalisation of approximately $11.5 billion and generated operating revenues of over $5 billion for the year ended 31 December 2014.

 

Markel and CATCo IM have entered into an agreement whereby Markel will acquire substantially all of the assets of CATCo IM, subject to the satisfaction of certain conditions. Upon completion of the acquisition which is expected to occur in the fourth quarter of 2015, the business will operate as Markel CATCo Investment Management Ltd. ("Markel CATCo"). Also upon completion of the acqusition, Markel CATCo will manage the Company.

 

Prior to completion of the acquisition, the Company will continue to operate and interact with its investment manager as normal, and there will be no changes to management personnel.

 

Upon completion of the acquisition, the existing CATCo IM management team, led by Chief Executive Officer Tony Belisle, will transition into corresponding roles at Markel CATCo and will continue to operate the business from its Hamilton, Bermuda headquarters, under Markel's ownership. Responsibility for existing and potential reinsurance market client relationships will remain with the CATCo IM team that will transition to Markel CATCo with the reinsurance business conducted as before. The existing CATCo IM senior management team will remain with the business and are incentivised to stay with the business for a minimum of three to five years.

 

The Company believes this is a progressive transaction for all stakeholders in that the combined strengths of these companies will further support the development of innovative structures and new products for reinsurance market clients.

 

Nigel Barton, Chairman, CATCo Reinsurance Opportunities Fund Ltd. said:

 

"The Board sees this as a very positive development for investors and reinsurance market clients alike. In bringing together the strengths of CATCo IM and Markel, the Board expects this transaction to generate future benefits for the Company's investors."

 

Tony Belisle, Chief Executive Officer of CATCo Investment Management Ltd. said: 

 

"We are excited to join forces with Markel, a leading global specialty insurer and reinsurer which operates with a strong commitment to its core values and distinguished corporate culture. We felt this partnership offered a rare opportunity for CATCo IM to combine with a culturally similar organization which shares our results-oriented commitment to success and market leadership.

 

"We are confident that uniting the strength of the Markel brand and its global reach with CATCo IM's differentiated product innovation capabilities will serve to improve our value proposition for investors and cedants. CATCo has grown significantly since its launch in 2010 and the agreement with Markel will allow the same management team to maintain its commitment to both client service and continued product development."

 

 

For further information:

 

Judith Wynne,

Company Secretary and General Counsel

CATCo Investment Management Ltd.

Telephone: +44 7986 205364

Email: judith.wynne@catcoim.com

 

Mark Way

Investor Relations Director

CATCo Investment Management Ltd.

Telephone: +44 7786 116991

Email: mark.way@catcoim.com

 

David Benda / Hugh Jonathan

Numis Securities Limited

Telephone: +44 (0) 20 7260 1000

 

 

- ends -

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQURAARVVAKARR
Date   Source Headline
24th Apr 20247:00 amRNSFinal Results
23rd Feb 20247:00 amRNSNet Asset Value(s)
23rd Nov 20237:00 amRNSNet Asset Value(s)
26th Sep 20237:00 amRNSHalf-year Report
29th Aug 20237:00 amRNSNet Asset Value(s)
7th Jun 20232:00 pmRNSResult of AGM
17th May 20237:00 amRNSNet Asset Value(s)
26th Apr 20237:00 amRNSFinal Results
16th Feb 20237:00 amRNSNet Asset Value(s)
2nd Dec 20227:00 amRNSHolding(s) in Company
30th Nov 20227:00 amRNSCompulsory Acqn of Shares
21st Nov 202211:42 amRNSCompulsory Acqn of Shares - correction
21st Nov 20227:00 amRNSCompulsory Acqn of Shares
2nd Nov 20227:00 amRNSNet Asset Value(s)
11th Oct 20222:00 pmRNSPrice Monitoring Extension
14th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20227:00 amRNSNet Asset Value(s)
11th Aug 20227:00 amRNSNet Asset Value(s) and Portfolio Update
2nd Aug 202210:38 amRNSHolding(s) in Company
22nd Jul 20227:00 amRNSNet Asset Value(s)
14th Jul 20227:00 amRNSNet Asset Value Reporting Change
12th Jul 20227:00 amRNSNet Asset Value(s)
7th Jun 20227:00 amRNSNet Asset Value(s)
1st Jun 20222:00 pmRNSResult of AGM
3rd May 202212:04 pmRNSDirectorate Change
28th Apr 20227:00 amRNSFinal Results
20th Apr 20224:25 pmRNSHolding(s) in Company
19th Apr 20221:44 pmRNSHolding(s) in Company
13th Apr 20224:41 pmRNSHolding(s) in Company
13th Apr 20222:48 pmRNSHolding(s) in Company
13th Apr 20222:46 pmRNSHolding(s) in Company
7th Apr 20227:00 amRNSPartial Compulsory Redemption of Shares
29th Mar 20227:00 amRNSScheme of arrangement - Closing Date
17th Mar 20227:00 amRNSScheme of arrangement - U.S. Bankruptcy Court
11th Mar 20224:46 pmRNSScheme of arrangement - Sanction of Schemes
10th Mar 20227:00 amRNSSOA - Chairperson’s Report on Scheme Meetings
7th Mar 20227:00 amRNSNet Asset Value(s)
7th Mar 20227:00 amRNSScheme of arrangement -Sanction Hearing & Timeline
28th Feb 20227:00 amRNSScheme of arrangement - Voting deadline 1 March
24th Feb 20227:00 amRNSScheme of arrangement - US Bankruptcy Court
18th Feb 20223:04 pmRNSScheme of arrangement - Notices of Scheme Meetings
17th Feb 20227:00 amRNSScheme of arrangement - Convening Order
14th Feb 20225:31 pmRNSScheme of arrangement - Directions Hearing
11th Feb 20227:00 amRNSScheme of arrangement - Amendment of Undertakings
7th Feb 20227:00 amRNSNet Asset Value(s)
4th Feb 20227:00 amRNSScheme of arrangement - improved terms
23rd Dec 20217:00 amRNSNet Asset Value(s)
13th Dec 20212:00 pmRNSScheme of arrangement - Update
10th Dec 20217:00 amRNSScheme of arrangement - Update
18th Nov 20211:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.